Literature DB >> 25043781

Traditional herbal medicines worldwide, from reappraisal to assessment in Europe.

Emiel van Galen1.   

Abstract

Since 2004 the regulatory framework within the European Union has a specific assessment procedure for herbal medicinal products, with a medicinal use based on traditional practice. The main requirement concerning the traditional use is focussed on the period of time for medical use: at least 30 years, including 15 years in the EU. In addition to requirements for quality and safety, an evaluation of pharmacological effects or efficacy based on long-standing use, is a main objective. "Traditional Use" however encompasses European, and non-European traditional use. Outside the EU, the medicinal use of herbal substances, preparations, and combinations is well-known, with a long history, which is well-documented in the different systems of medical practice. This has been addressed by WHO, but it has been acknowledged also by European Commission that herbal products from other systems of medicine, can be subject to the procedure for traditional herbal medicinal products. This paper will focus on the possibilities, restraints, and challenges of regulatory practice in the European Union regarding these category of medicinal products.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Keywords:  Ayurveda; Committee on herbal medicinal products; Community herbal monographs; Traditional chinese medicine; Traditional herbal medicinal products

Mesh:

Substances:

Year:  2014        PMID: 25043781     DOI: 10.1016/j.jep.2014.07.013

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb.

Authors:  Florence P A M van Hunsel; Djurre van der Kooi; Sonja van de Koppel; Burt H Kroes; Herman J Woerdenbag
Journal:  Drug Saf       Date:  2022-05-24       Impact factor: 5.606

2.  Antibacterial Activity of Four Plant Extracts Extracted from Traditional Chinese Medicinal Plants against Listeria monocytogenes, Escherichia coli, and Salmonella enterica subsp. enterica serovar Enteritidis.

Authors:  R L McMurray; M E E Ball; M M Tunney; N Corcionivoschi; C Situ
Journal:  Microorganisms       Date:  2020-06-26

Review 3.  Internationalization of Traditional/Complementary Medicine products: market entry as medicine.

Authors:  Jiatong Li; Jianfan Zhu; Hao Hu; Joanna E Harnett; Chi Ieong Lei; Ka Yin Chau; Ging Chan; Carolina Oi Lam Ung
Journal:  Chin Med       Date:  2018-10-11       Impact factor: 5.455

4.  Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of Terminalia arjuna (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats.

Authors:  Gaurav Kumar; Nikhat Saleem; Santosh Kumar; Subir K Maulik; Sayeed Ahmad; Manish Sharma; Shyamal K Goswami
Journal:  Front Pharmacol       Date:  2019-12-10       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.